Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 313.41% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -588.64% vs 90.41% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 70.28% vs -132.52% in Jun 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Day One Biopharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 10.06% vs 5.48% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 313.41% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 15.83% vs 45.21% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -588.64% vs 90.41% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 15.42% vs 37.77% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 70.28% vs -132.52% in Jun 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






